Effect of Pulsed Electromagnetic Stimulation on DOMS

Sponsor
Pamukkale University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05554874
Collaborator
(none)
60
2
2

Study Details

Study Description

Brief Summary

The aim of our study is to investigate the effect of Pulsed Electro Magnetic Field application on delayed muscle soreness in healthy Quadriceps femoris muscle.

Condition or Disease Intervention/Treatment Phase
  • Other: Pulsed electromagnetic fields
  • Other: Sham Pulsed electromagnetic fields
N/A

Detailed Description

Participants will complete 100 consecutive fall jumps from a 0.60 m high platform to generate Delayed muscle soreness. After landing, participants will be encouraged to jump vertically immediately with maximum force. Five sets of 20 jumps will be performed with 10-second intervals between each jump, with a 2-minute rest between sets.Immediately after the implementation of the exercise protocol that will cause delayed muscle soreness, the participants will be randomly divided into 2 groups. Pulsed Electromagnetic Field or sham Pulsed Electromagnetic Field application will be applied to the non-dominant extremities of the participants.

The participants will be evaluated before (0), 24, 48 and 72 hours after the delayed muscle pain protocol.

Pain intensity of the participants will be evaluated with Visual Pain Scale (VAS), muscle fatigue will be evaluated with Modified Borg Scale, muscle performance will be evaluated with one-leg jump test, and muscle tenderness will be evaluated with an algometer.

In addition, serum creatine kinase and myoglabin values will be tested by laboratory analysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Real or sham pulsed electromagnetic fieldsReal or sham pulsed electromagnetic fields
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Pulsed Electromagnetic Stimulation on DOMS: A Randomized Sham-controlled Trial.
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Case group

participants undergoing pulsed electromagnetic fields

Other: Pulsed electromagnetic fields
receiving Pulsed electromagnetic fields 3 times, immediately after the onset of delayed muscle soreness, 24 and 48 hours later.

Sham Comparator: Control group

participants undergoing sham pulsed electromagnetic fields

Other: Sham Pulsed electromagnetic fields
Sham application will be applied with the same device without applying magnetic current.

Outcome Measures

Primary Outcome Measures

  1. Pain intensty [up to 72 hours]

    assessed with VAS

  2. Muscle fatigue [up to 72 hours]

    Borg scale

  3. Muscle performance [up to 72 hours]

    Single leg hop test

  4. Muscle tenderness [up to 72 hours]

    Algometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • not having any systemic disease

  • not having neuromuscular deficit

  • not having knee pathology

  • To be defined as inactive (less than 30 minutes of moderate physical activity five times a week) according to the minimum activity guidelines published by the American College of Sports Medicine

Exclusion Criteria:
  • Being actively involved in any sport

  • participating in a regular exercise program

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Pamukkale University

Investigators

  • Study Chair: Ummuhan Bas Aslan, Prof, Prof Dr.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Şule ŞİMŞEK, Principal investigator, Pamukkale University
ClinicalTrials.gov Identifier:
NCT05554874
Other Study ID Numbers:
  • 17.05.2022/08
First Posted:
Sep 26, 2022
Last Update Posted:
Oct 12, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Şule ŞİMŞEK, Principal investigator, Pamukkale University

Study Results

No Results Posted as of Oct 12, 2022